Profile data is unavailable for this security.
About the company
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.
- Revenue in HKD (TTM)372.84m
- Net income in HKD-1.60bn
- Incorporated2009
- Employees1.49k
- LocationCanSino Biologics IncWest District Biomedical Park, No. 185South Avenue, West District, EconomicTIANJIN 300457ChinaCHN
- Phone+86 2 258213766
- Fax+86 2 258213626
- Websitehttp://www.cansinotech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| New Horizon Health Ltd | 1.47bn | 119.49m | 6.47bn | 1.04k | 59.14 | 2.01 | 41.60 | 4.40 | 0.2391 | 0.2391 | 3.22 | 7.05 | 0.4536 | 2.16 | 2.08 | 1,675,510.00 | 3.67 | -- | 3.99 | -- | 88.74 | -- | 8.10 | -- | 10.50 | -- | 0.1305 | -- | 259.54 | -- | 97.40 | -- | -- | -- |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 874.06m | 110.37m | 6.59bn | 948.00 | 20.88 | 0.9109 | -- | 7.54 | 0.1073 | 0.1073 | 0.8301 | 2.46 | 0.2852 | 1.44 | 1.62 | 922,008.60 | 3.59 | 7.03 | 4.35 | 9.05 | 91.40 | 92.17 | 12.59 | 17.26 | 3.94 | 568.37 | 0.0062 | 39.16 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | 0.00 |
| Tong Ren Tang Technologies Co Ltd | 7.32bn | 637.47m | 7.57bn | 4.10k | 11.87 | 1.02 | 5.53 | 1.03 | 0.4977 | 0.4977 | 5.71 | 5.81 | 0.5212 | 0.9835 | 5.68 | 1,783,984.00 | 7.64 | 7.68 | 12.10 | 12.32 | 42.04 | 43.50 | 14.65 | 16.11 | 2.37 | -- | 0.1443 | 39.94 | 13.04 | 6.01 | 1.25 | -2.73 | -22.26 | 0.0178 |
| Everest Medicines Ltd | 136.02m | -912.12m | 7.63bn | 432.00 | -- | 1.40 | -- | 56.10 | -2.92 | -2.92 | 0.4345 | 16.80 | 0.0203 | 2.25 | 4.57 | 314,863.40 | -13.63 | -30.52 | -15.06 | -33.14 | 72.67 | -- | -670.57 | -5,745.25 | 8.29 | -- | 0.0979 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
| China Shineway Pharmaceutical Group Ltd | 4.88bn | 1.05bn | 7.75bn | 3.44k | 6.76 | 1.02 | 6.32 | 1.59 | 1.39 | 1.39 | 6.46 | 9.19 | 0.5073 | 1.44 | 6.31 | 1,419,784.00 | 10.89 | 8.03 | 14.15 | 9.77 | 75.15 | 74.55 | 21.47 | 17.87 | 2.98 | -- | 0.0411 | 36.29 | 14.32 | 11.94 | 34.14 | 13.89 | 0.6396 | 12.88 |
| Beijing Tong Ren Tang Chinese Medicine | 1.52bn | 540.39m | 8.54bn | 798.00 | 15.80 | 2.21 | 12.69 | 5.60 | 0.6456 | 0.6456 | 1.82 | 4.62 | 0.3522 | 0.6449 | 2.31 | 1,910,959.00 | 13.64 | 16.71 | 15.50 | 18.75 | 68.67 | 69.88 | 38.73 | 40.72 | 8.59 | -- | 0.0317 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
| Lepu Biopharma Co Ltd | 243.41m | -23.87m | 8.61bn | 429.00 | -- | 8.89 | 110.55 | 35.38 | -0.0144 | -0.0144 | 0.1467 | 0.5838 | 0.0917 | 1.06 | 1.62 | 567,379.90 | -1.23 | -- | -1.91 | -- | 87.45 | -- | -13.45 | -- | 0.7201 | 0.1388 | 0.4549 | -- | 1,347.16 | -- | 96.79 | -- | -- | -- |
| Cansino Biologics Inc | 372.84m | -1.60bn | 9.35bn | 1.49k | -- | 0.9453 | -- | 25.07 | -6.49 | -6.49 | 1.51 | 23.06 | 0.0332 | 2.37 | 0.4619 | 249,555.60 | -18.93 | -4.27 | -26.69 | -5.60 | -253.78 | -- | -569.97 | -27.72 | 1.86 | -- | 0.3381 | -- | -66.52 | 213.94 | -63.04 | -- | 30.60 | -- |
| AIM Vaccine Co Ltd | 1.28bn | -1.41bn | 9.47bn | 1.62k | -- | 2.41 | -- | 7.38 | -1.16 | -1.16 | 1.06 | 3.25 | -- | -- | -- | 789,779.30 | -- | -- | -- | -- | 75.88 | -- | -164.24 | -- | 0.7583 | -14.04 | 0.3158 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
| Yichang Hec Changjiang Pharmactcl Co Ltd | 6.80bn | 2.15bn | 9.56bn | 4.62k | 4.44 | 1.11 | 3.94 | 1.41 | 2.45 | 2.45 | 7.73 | 9.74 | 0.5111 | 3.62 | 4.09 | 1,472,255.00 | 15.07 | 8.03 | 24.46 | 11.81 | 79.21 | 79.97 | 29.48 | 20.80 | 1.30 | 11.16 | 0.2475 | 15.81 | 68.08 | 20.18 | 2,501.24 | 16.15 | -11.50 | -- |
| Shanghai Henlius Biotech Inc | 5.83bn | 589.76m | 9.71bn | 3.64k | 16.51 | 4.10 | 9.93 | 1.67 | 1.08 | 1.08 | 10.68 | 4.36 | 0.5731 | 1.95 | 9.10 | 1,602,178.00 | 5.80 | -8.59 | 12.47 | -14.14 | 72.64 | 71.77 | 10.12 | -27.37 | 0.3786 | 6.48 | 0.6512 | -- | 67.82 | 273.51 | 178.53 | -- | 49.14 | -- |
| InnoCare Pharma Ltd | 797.70m | -681.84m | 9.91bn | 1.09k | -- | 1.16 | -- | 12.43 | -0.4043 | -0.4043 | 0.4727 | 4.38 | 0.073 | 1.39 | 3.39 | 732,511.10 | -6.38 | -13.41 | -8.08 | -15.36 | 82.61 | 85.99 | -87.42 | -172.16 | 4.13 | -- | 0.1582 | -- | 18.09 | 240.36 | 28.80 | -- | 66.20 | -- |
| Keymed Biosciences Inc | 382.46m | -388.15m | 10.73bn | 897.00 | -- | 3.33 | -- | 28.05 | -1.49 | -1.49 | 1.45 | 11.53 | 0.0906 | 0.7314 | 26.14 | 426,380.40 | -9.16 | -- | -10.05 | -- | 89.59 | -- | -101.04 | -- | 9.18 | -- | 0.123 | -- | 253.87 | -- | -16.63 | -- | -- | -- |
| Luye Pharma Group Ltd | 6.64bn | 575.27m | 11.21bn | 5.27k | 19.39 | 0.8282 | 8.36 | 1.69 | 0.1537 | 0.1537 | 1.78 | 3.60 | 0.247 | 2.42 | 3.60 | 1,259,057.00 | 2.17 | 2.80 | 3.56 | 4.45 | 68.44 | 70.53 | 8.78 | 10.39 | 1.21 | 3.10 | 0.3931 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
| SciClone Pharmaceuticals (Holdings) Ltd | 3.41bn | 1.21bn | 11.51bn | 1.05k | 9.83 | 3.13 | 8.41 | 3.38 | 1.86 | 1.86 | 5.24 | 5.84 | 0.7585 | 3.56 | 3.83 | 3,246,119.00 | 26.97 | 27.09 | 33.34 | 36.32 | 74.67 | 76.06 | 35.55 | 35.43 | 4.50 | 33.70 | 0.01 | 22.98 | 14.76 | 17.50 | 31.16 | 15.96 | 25.65 | -- |
Data as of May 21 2024. Currency figures normalised to CanSino Biologics Inc's reporting currency: Hong Kong Dollar HKD
9.09%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 09 May 2024 | 3.25m | 2.45% |
| BlackRock Fund Advisorsas of 29 Nov 2022 | 2.88m | 2.17% |
| DSM Capital Partners LLCas of 31 Mar 2023 | 1.38m | 1.04% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2024 | 893.52k | 0.67% |
| BlackRock Advisors (UK) Ltd.as of 29 Nov 2022 | 879.00k | 0.66% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 724.00k | 0.55% |
| BlackRock (Netherlands) BVas of 29 Nov 2022 | 678.69k | 0.51% |
| BlackRock Japan Co. Ltd.as of 29 Nov 2022 | 541.22k | 0.41% |
| BlackRock Investment Management (UK) Ltd.as of 29 Nov 2022 | 418.66k | 0.32% |
| Dimensional Fund Advisors LPas of 09 May 2024 | 409.60k | 0.31% |
More ▼
Data from 31 Mar 2024 - 16 May 2024Source: FactSet Research Systems Inc.
